| Net income (loss) | -15.1M |
| Depreciation and amortization | |
| Amortization of intangible assets | 392K |
| Allowance on notes receivable | |
| Provision for doubtful accounts | |
| Equity in earnings of unconsolidated subsidiary, net of dividends received | |
| Amortization of debt issuance costs | 124K |
| Deferred income taxes | -3.58M |
| Loss on disposal of property and equipment | |
| Gain on sale of business | |
| Stock based compensation expense | 1.33M |
| Tax benefit from stock option plans | |
| Trade and other receivables, net | 5.24M |
| Costs and estimated earnings in excess of billings on uncompleted contracts, net | |
| Inventories | 8.93M |
| Refundable income taxes | 3.07M |
| Prepaid expenses and other assets | 710K |
| Accounts payable | 489K |
| Accrued and other liabilities | -3.3M |
| Net cash used in operating activities | |
| Additions to property and equipment | -1.79M |
| Proceeds from sale of business | 0 |
| Other investing activities | |
| Issuance of note receivable | |
| Proceeds from the sale of property and equipment | 20K |
| Net cash provided by (used in) investing activities | |
| Proceeds from issuance of common stock | |
| Tax withholdings related to net share settlements of restricted stock awards and performance shares | -31K |
| Payments on long-term debt | |
| Borrowings under note payable to financial institution | |
| Payments on note payable to financial institution | |
| Borrowings from capital lease obligations | |
| Payments on capital lease obligations | -292K |
| Payments of debt amendment costs | |
| Net cash provided by financing activities | |
| Change in cash and cash equivalents | 1.5M |
| Cash and cash equivalents, beginning of period | 10.31M |
| Cash and cash equivalents, end of period | 11.81M |
| Escrow account related to capital lease financing | |
| Accrued property and equipment purchases | 147K |